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ABSTRACT 
Objective: To develop a novel, accurate, precise and linear reverse phase high performance liquid chromatographic (RP-HPLC) method for 
simultaneous qualitative and quantitative estimation of quercetin, ellagic acid and rutin in an ayurvedic formulation and validate as per 
international conference on harmonization (ICH) guidelines. 
Methods: In the present work, good chromatographic separation was achieved isocratically using a shim-pack HPLC C18 column (4.6 x 250 mm, 
5μm) and a mobile phase consisting of 0.02 M potassium dihydrogen orthophosphate buffer (pH adjusted to 3 with orthophosphoric acid) and 
methanol in the ratio 55:45, at flow rate of 1 ml/min and column temperature maintained at 35 °C. The effluents obtained were monitored at 254 
nm with a UV-visible detector. 
Results: The retention time of quercetin, ellagic acid and rutin were found to be 7.52 min, 9.10 min and 12.47 min respectively. Linearity of 
quercetin, ellagic acid and rutin were found in the range of 8-12 ppm, 9-17 ppm and 7-11 ppm respectively. The correlation coefficient for 
quercetin, ellagic acid and rutin were 0.997, 0.999 and 0.999 respectively. The high recovery values (98 %-102 %) indicate a satisfactory accuracy. 
The low percent relative standard deviation (% RSD) values in the precision study reveal that the method is precise. 
Conclusion: The developed method is novel, simple, precise, rapid, accurate and reproducible for simultaneous quantitative estimation of 
quercetin, ellagic acid and rutin in an ayurvedic formulation. Hence the developed method can be used for quantitative analysis and quality control 
of extracts and commercial samples of other plant species and formulation containing these three markers. 
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Ayurvedic medicines are polyherbal formulations and every herb 
consists of an array of chemical constituents. Hence, each ayurvedic 
formulation is a source of many different phytochemicals, which 
individuals may have different medicinal properties. The 
standardization parameters set for such polyherbal formulations are 
inadequate and therefore quality specifications are not stringent. 
Standardization is an important parameter for maintaining and 
accessing the safety and quality of herbal medicines as they are 
comprised of many chemical constituents and are capable of 
variation [1] Therefore, the development of various novel analytical 
techniques for the analysis of medicinally active phytoconstituents 
has become a crucial step of standardization. The information 
generated from high-performance thin layer chromatography 
(HPTLC) and high-performance liquid chromatography (HPLC) 
fingerprint profiles have a potential application in deciding the 
identity, purity, and strength of herbal medicines and for fixing 
standards for herbal formulations [2]. 
Triphala churna is (1:1:1) combination of three compounds viz. 
Terminalia chebula, Terminalia belerica and Terminalia officinalis 
each of which has its own therapeutic value, but in combination, it 
enhances the overall potential these are used mostly as an 
antioxidant, anti-aging, anti-inflammatory, mental and memory 
enhancing the effect. The extract of triphala was obtained by using a 
soxhlet extraction process and methanol, water in a ratio (70:30). A 
marker which has been found in triphala by the various method are 
quercetin, rutin, gallic acid, ellagic acid, ascorbic acid and known for 
its effect [3]. In the present study, we have selected three chemical 
markers namely quercetin, ellagic acid and rutin. 
The literature survey reveals that various analytical methods for 
estimation of quercetin, ellagic acid and rutin were reported alone 
and in combination with other drugs [3-8] also simultaneous 
estimation of gallic acid, catechin, rutin, ellagic acid and quercetin in 
flower extract of Michelia alba, Caesalpinia pulcherrima and Nelumbo 
nucifera by HPLC reported [9] but to the best of our knowledge there 
is no such reported HPLC analysis method for simultaneous 
estimation of quercetin, ellagic acid and rutin in triphala churna. 
In the present investigation, we have developed a simple, optimized 
and validated HPLC method for the standardization of triphala 
churna ayurvedic formulation using three chemical markers namely 
quercetin, ellagic acid and rutin. The method was validated as per 
the international conference on harmonization (ICH) guidelines. 
This novel validated method has applicability in an industry as well 
as in academia. 
MATERIALS AND METHODS 
HPLC grade quercetin, ellagic acid and rutin (purity 99%) were 
procured as gift sample from Yucca Enterprises, Mumbai, India. An 
ayurvedic preparation Zandu triphala churna (Zandu 
Pharmaceutical Works Ltd.) used for analysis was procured from 
local market. HPLC grade solvents were purchased from Thomas 
Baker. RP-HPLC shimadzu (LC 2030) model with “Lab Solution” 
software was employed in this method. Analytical column used for 
the separation of analytes was shim-pack HPLC C18 (250 X 4.6 mm, 
5 µm).  
Methods 
Selection of wavelength 
Suitable wavelength for the HPLC analysis was determined by 
recording UV spectrums in the range of 200-400 nm for individual 
drug solutions of quercetin, ellagic acid and rutin then overlapped. 
UV overlain spectra of these three markers showed that the drugs 
absorb appreciably at 254 nm and hence 254 nm was taken as a 
detection wavelength for HPLC analysis (fig. 1). 
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Fig. 1: UV overlap spectrum of quercetin, ellagic acid and rutin 
 
Chromatographic conditions 
The method was developed using reverse phase, shim-pack HPLC C18 
column (250 X 4.6 mm, 5 µm). The runtime was of 20 min. The mobile 
phase used was 0.02 M potassium dihydrogen orthophosphate buffer 
(pH adjusted to 3 with orthophosphoric acid) and methanol in the ratio 
55:45 at a flow rate of 1.0 ml/min, column temperature maintained at 35 
°C and a detection wavelength of 254 nm using a UV-visible detector. 
Preparation of 0.02 M phosphate buffer (pH 3) 
About 3.48 g of potassium dihydrogen orthophosphate was 
accurately weighed and dissolved in 950 ml of water. The pHwas 
adjusted to 3 with orthophosphoric acid and the volume was made 
up to 1000 ml in a volumetric flask. The solution was then filtered 
using 0.45 µ membrane filter. 
Preparation of standard solution 
100 mg of quercetin, ellagic acid and rutin standard were accurately 
weighed and transferred into 100 ml volumetric flask respectively. 
About 70 ml solvent was added, sonicated to dissolve and diluted up 
to the mark using a solvent (1000 ppm). The final concentration of 
quercetin, ellagic acid and rutin were made to 10 ppm, 13 ppm and 9 
ppm respectively by suitable dilutions. 
Sample preparation 
Accurately about 500 mg of triphala churna was extracted with 100 
ml methanol and water in the ratio (70:30). The sample solution was 
filtered to obtain a clear solution. The stock solution after suitable 
dilutions was used for further analysis. 
RESULTS AND DISCUSSION  
Method development  
A reverse phase HPLC method was developed keeping in mind the 
system suitability parameters, i.e. resolution factor between peaks, 
tailing factor, number of theoretical plates, runtime and the cost-
effectiveness. The developed optimized method resulted in the 
elution of quercetin at 7.52 min, ellagic acid at 9.10 min and rutin at 
12.47 min. fig. 2,3 and 4 represent chromatograms of quercetin, 
ellagic acid and rutin standard solution respectively. The total run 
time was 20 min. System suitability tests are an integral part of 
method development and are used to ensure adequate performance 
of the chromatographic system. Retention time, a number of 
theoretical plates, peak resolution and peak tailing factor were 
evaluated for six replicate injections of the standard working 
concentration. The results given in table 1 were within the 
acceptable limits [10, 11]. 
 
 
Fig. 2: Typical chromatogram of quercetin standard solution 
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Fig. 3: Typical chromatogram of ellagic acid standard solution 
 
 
Fig. 4: Typical chromatogram of rutin standard solution 
 
Table 1: Results of system suitability studies 
Parameters Acceptance limits Quercetin Ellagic acid  Rutin  
Retention time (min) - 7.52 9.10  12.47  
Resolution factor Not less than 2 - 3.04 7.10 
Number of theoretical plates Not less than 2000 3436 4147 3786 
Tailing factor Not more than 2 1.20 1.35 1.21 
 
To test the applicability of the developed method to an ayurvedic 
formulation, triphala churna extract was chromatographed and it is 
shown in fig. 5. The sample peaks were identified by comparing the 
relative retention times with standard markers (fig. 2-4). System 
suitability parameters were within the acceptable limits, ideal for 
the chromatographed sample. Integration of the separated peak area 
was done, and each marker concentration was determined by using 
the peak area concentration relationship obtained in the 
standardization step. For the analysis, of the sample, extract of 1000 
ppm of triphala churna was injected in triplicate and quantified for 
three active markers using a linear regression equation. The results 
of churna extract analysis are reported in table 2. 
 
Table 2: Analysis of triphala churna extract 
Formulation  Marker  Amount found (ppm) n=3 Content (%) 
Triphala churna extract 
(1000 ppm) 
Quercetin  9.49 0.94 
Ellagic acid 11.33 1.13 
Rutin  8.12 0.81 
# n: number of injections 
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Fig. 5: Typical chromatogram of triphala churna extract 
 
Method validation  
Validation of the analytical method is the process that establishes by 
laboratory studies in which the performance characteristics of the 
method meet the requirements for the intended analytical 
application. The developed HPLC method was validated according to 
ICH guidelines [12] for validation of analytical procedures. The 
method was validated for the parameters like linearity, accuracy, 
system precision, method precision, robustness, limit of detection 
(LOD) and limit of quantitation (LOQ). 
Specificity 
Fig. 2-5 for standard drug solutions and sample chromatogram 
reveals that the peaks obtained in the standard solutions and sample 
solution at working concentrations are only because of the drugs as 
blank has no peak at the retention time of quercetin, ellagic acid and 
rutin. Accordingly, it can be concluded that the method developed is 
said to be specific [13, 14]. 
Precision 
System precision 
Six replicate injections of the standard solutions at working 
concentration showed percent relative standard deviation (% RSD) 
less than 2 concerning the peak area for each marker, which 
indicates the acceptable reproducibility and thereby the precision of 
the system [15, 16]. System precision results are tabulated in table 3. 
Method precision  
Method precision was determined by performing the analysis of the 
sample under the test of repeatability at working concentration. Six 
injections of the sample from the same homogeneous mixture at 
working concentration showed % RSD less than 2 concerning the 
content of three markers indicate that the method developed is 
precise by the test of repeatability [15, 16] and hence can be 
understood that the method gives consistently reproducible results 
(table 4). 
 
Table 3: System precision results 
S. No. Peak area of quercetin 
(10 ppm) 
Peak area of ellagic acid 
(13 ppm) 
Peak area of rutin 
(9 ppm) 
1 1327837 2604837 1234879 
2 1328687 2618638 1208688 
3 1347656 2628765 1218766 
4 1332596 2608767 1215678 
5 1328677 2618638 1226875 
6 1387632 2610876 1218766 
mean±SD 1342181±23485 2615087±8661 1220609±9123 
%RSD 1.75 0.33 0.75 
# SD: Standard deviation, # %RSD: Percent relative standard deviation 
 
Table 4: Method precision results 
Marker Intra-day   Inter-day  
Content (ppm) n=3 mean±SD  % RSD Content (ppm) n=3 mean±SD %RSD 
Quercetin 9.49±0.02  0.21 9.46±0.04 0.45 
Ellagic acid 11.30±0.03 0.26 11.34±0.01 0.13 
Rutin 8.11±0.01 0.12 8.14±0.02 0.30 
# n: number of injections, # SD: Standard deviation, # %RSD: Percent relative standard deviation 
 
Linearity 
Standard solutions of quercetin, ellagic acid and rutin at different 
concentration level were prepared in triplicates. Calibration curves 
were constructed by plotting the concentration level versus 
corresponding peak areas for each marker. The results show an 
excellent correlation between peak areas and concentrations level 
within the tested concentration range of 8-12 ppm, 9-17 ppm and 7-
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11 ppm for quercetin, ellagic acid and rutin respectively (table 5). 
The correlation coefficients were greater than 0.99 for each marker, 
which meets the method validation acceptance criteria [11, 15, 16] 
and hence the method is said to be linear. 
 
Table 5: Data from linearity studies 
Marker Concentration range (ppm) Regression equation  R2 
Quercetin   8-12 Y=96471x+360471 0.997 
Ellagic acid  9-17 Y=146896x+689023 0.999 
Rutin   7-11 Y=108009x+290274 0.999 
 
Accuracy 
Accuracy was determined by means of recovery experiments, by the 
determination of % mean recovery of each compound in the 
formulation at three distinct levels (80%, 100% and 120%). At each 
level, three determinations were performed. Percent mean recovery 
was calculated as shown in table 6. The accepted limits of mean 
recovery are 98%-102% and all observed data were within the 
required range, which indicates good recovery values, affirming the 
accuracy of the method developed [15, 16]. 
 
Table 6: Recovery study for three markers in triphala churna 












Quercetin  4.74 3.79 8.53 1197828 8.67  101.75 
  4.74 9.48 1276479 9.49 100.15 
  5.68 10.42 1347890 10.23 98.22 
Ellagic acid 5.66 4.53 10.19 2210231 10.35 101.62 
  5.66 11.32 2357891 11.36 100.36 
  6.79 12.45 2515343 12.43 99.86 
Rutin 4.06 3.24 7.30 1097539 7.47 102 
  4.06 8.12 1158998 8.04 99.05 
  4.87 8.93 1257656 8.95 100.29 
# n: Number of injections 
 
Robustness 
To determine the robustness of the developed method, experimental 
conditions were deliberately altered, and the system suitability 
parameter tailing factor and peak area were evaluated. The solution 
was prepared as per the test method described earlier and injected 
at different variable conditions like column temperature (33 °C and 
37 °C) and detection wavelength (253 nm and 255 nm). Robustness 
data clearly show that the proposed method is robust at small but 
deliberate change [15, 16]. Robustness data are given in table 7. 
 
Table 7: Robustness data for quercetin, ellagic acid and rutin 
Parameters  Quercetin (10 ppm) Ellagic acid (13 ppm)  Rutin (9 ppm) 
Peak area Tailing factor Peak area Tailing factor Peak area Tailing factor  
Minus temp [33 °C] 1327876 1.17 2604837 0.98 1232794 1.03 
Plus temp [37 °C] 1329968 1.09 2618768 0.97 1208778 0.99 
Minus wavelength [253 nm] 1337567 0.99 2628767 0.93 1213434 1.17 
Plus wavelength [255 nm]  1318767 1.37 2606787 0.82 1229697 1.09 
 
Sensitivity  
The sensitivity of measurement of quercetin, ellagic acid and rutin 
by use of the proposed method was estimated in terms of the LOQ 
and LOD. LOQ and LOD were calculated using the equations LOD = 
3.3σ/S and LOQ = 10σ/S where σ is the standard deviation of 
intercepts of calibration plots and S is the average of the slopes of 
the corresponding calibration plot (table 8). 
 
Table 8: LOD and LOQ for quercetin, ellagic acid and rutin 
Compound LOD (ppm) LOQ (ppm) 
Quercetin  0.80  2.43 
Ellagic acid 0.19 0.58 
Rutin  0.27 0.84 
#LOD: limit of detection, #LOQ: limit of quantitation 
 
In previous report [9] HPLC method was developed for 
simultaneous estimation of gallic acid, catechin, rutin, ellagic acid 
and quercetin using Luna C18 column (4.6 x 250 mm, 5μm) with 
gradient elution, whereas this study uses a novel column shim-pack 
HPLC C18 column (4.6 x 250 mm, 5μm) with isocratic elution. In 
HPLC method development isocratic elution is simpler than gradient 
elution because in the gradient elution column has to re-equilibrate 
to original conditions after each run and thus takes additional time. 
Weersak S. et al. in 2007 for their study uses water-acetic acid and 
methanol as mobile phase, whereas the present investigation uses 
novel mobile phase consisting of 0.02 M potassium dihydrogen 
orthophosphate buffer (pH adjusted to 3 with orthophosphoric acid) 
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and methanol in the ratio 55:45. Moreover, various analytical 
methods for these three markers alone or in combination with other 
drugs exist [3-8] but the method developed in this report is first of 
its kind and is useful in the qualitative and quantitative analysis of 
quercetin, ellagic acid and rutin from complex herbal mixture 
formulation. 
CONCLUSION 
The results indicate that the selected ayurvedic formulation contains 
a number of markers that may be responsible for its therapeutic 
activity. The developed HPLC method will assist in the 
standardization of triphala churna using biologically active chemical 
markers. The developed HPLC method for simultaneous 
determination of quercetin, ellagic acid and rutin from triphala 
churna is accurate, precise, reproducible and repeatable. Triphala 
churna also contains a number of other constituents, which are 
currently the subject of further investigation, apart from those 
standards studied. With the growing demand for herbal drugs and 
increased belief in the use of herbal medicine, the development of a 
standardization tool will help in maintaining the quality of this 
important ayurvedic preparation. 
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